Labad and collaborators [33] demonstrated the relevance of genetic variants in UGT1A8 and oestrogen receptor 1 genes in the modulation of response to raloxifene in postmenopausal women with schizophrenia [33]. The gene discussed is UGT1A8; the disease is schizophrenia.